Search

everythinglearnresearchcommunity

for

Search:↓

Lactobacillus plantarum hydrolysates may help increase hair growth by boosting VEGF production.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Possible link between androgens and COVID-19 severity; more research needed.

Men had worse COVID-19 outcomes than women in New York City.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Genetic differences affect COVID-19 severity and treatment effectiveness.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

CD99 is highly present in certain skin cells and could help treat skin conditions.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Minoxidil can cause severe body swelling and fluid buildup, which improves after stopping the drug and using diuretics.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Using existing drugs for new treatments is cost-effective and safer.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.